By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arrowhead Research Corporation 

1118 East Green Street

Pasadena  California  91106  U.S.A.
Phone: 626-792-5549 Fax: 626-792-5554


Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silence disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead’s pipeline includes clinical programs in chronic hepatitis B virus and obesity and partner-based programs in oncology.

Key Statistics

Ownership: Public

Web Site: Arrowhead Research Corporation
Symbol: ARWR

Medical Device

Company News
Novartis AG (NVS) Unloads RNAi Portfolio to Arrowhead Research Corporation (ARWR) for $35 Million 3/5/2015 6:08:11 AM
Arrowhead Research Corporation (ARWR) To Present At 2015 Barclays Global Healthcare Conference 3/4/2015 11:22:02 AM
Arrowhead Research Corporation (ARWR) Begins Phase 1 Trial Of ARC-AAT For Treatment Of Liver Disease Associated With Alpha-1 Antitrypsin Deficiency 2/23/2015 12:07:02 PM
Arrowhead Research Corporation (ARWR) To Present At 2015 RBC Capital Markets' Global Healthcare Conference 2/18/2015 1:38:46 PM
Arrowhead Research Corporation (ARWR) Reports Fiscal 2015 First Quarter Financial Results 2/10/2015 12:00:55 PM
Arrowhead Research Corporation (ARWR) To Report Fiscal 2015 First Quarter Financial Results 2/3/2015 12:04:00 PM
Arrowhead Research Corporation (ARWR) Provides Update On IND For ARC-520 Phase 2b Study 1/12/2015 12:28:08 PM
Arrowhead Research Corporation (ARWR) Soars on Rumor of Gilead Sciences, Inc. (GILD)'s Interest 12/31/2014 6:34:56 AM
Arrowhead Research Corporation (ARWR) Files IND For RNAi Therapeutic ARC-520 To Begin Phase 2b Multiple-Dose Studies In Chronic Hepatitis B Patients 12/15/2014 9:42:45 AM
Arrowhead Research Corporation (ARWR) Appoints Patrick O’Brien As General Counsel 12/5/2014 9:24:53 AM